Once chronic hyperglycemia is corrected, GIP-mediated insulin secretion is restored [78], allowing tirzepatide to enhance insulin secretion through both the GIP and GLP-1 receptors (Fig. 2). Here, GLP1R is linked to Hyperglycemia.